This most current twist inside the Lykos Therapeutics saga threatens A serious overhaul of the business’s tactic and route, with Musk ally and billionaire investor Antonio Gracias appearing to desire to acquire the corporate back again towards its nonprofit drug growth roots and a far more Doblinite philosophy.Incredible but not for your faintest